Clinical trial

Cancer Venous Thromboembolism (VTE)

NCT02073682

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-07-16

PhasePHASE3

Study timeline

Study start (actual)2015-07-16Date precision: day

Registry last updated2019-03-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Venous Thromboembolism (VTE)unresolved

Deep Vein Thrombosis (DVT)unresolved

Pulmonary Embolism (PE)unresolved

Cancerunresolved

Interventions

EdoxabanDRUG · verified · RxNorm: edoxaban

DalteparinDRUG · verified · RxNorm: dalteparin

Low molecular weight heparinDRUG

Sponsors & collaborators

Daiichi Sankyolead sponsor

Mapped research locations

DetroitMichigan, United States1 AmsterdamNetherlands1 NorfolkVirginia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02073682 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.